Press Releases

Flagship Pioneering and its portfolio companies make news because of their transformative approaches to solving global challenges. If you have needs beyond these resources, please contact press@flagshippioneering.com.

company

year

domain

MaxCyte and KSQ Therapeutics Announce Development and Commercialization Agreement to Enable the Advancement of KSQ's Adoptive Cell Therapy Programs

KSQ Therapeutics 12.04.2019

KSQ Therapeutics Enhances Board of Directors with Two Appointments

KSQ Therapeutics 11.12.2019

KSQ Therapeutics Announces Appointment Of Beni B. Wolf, MD, PhD, As Chief Medical Officer

KSQ Therapeutics 04.16.2019

KSQ Therapeutics Announces Appointment of Douglas Pagán as Chief Financial Officer

KSQ Therapeutics 04.16.2019

KSQ Therapeutics Secures $80 Million Financing And Advances Broad Pipeline Of Cancer Therapies Including Its First Adoptive T-Cell Therapy Program For PD 1 Resistant Solid Tumors

KSQ Therapeutics 09.28.2018

KSQ Therapeutics Emerges With $76 Million In Financing To Pioneer High-Confidence Drug Development

KSQ Therapeutics 10.02.2017

Loading